Michal A Stanczak

7PUBLICATIONS
66CO-AUTHORS
AllergyBiological adaptationHaematological tumoursTumour immunologyHuman impacts of climate change and human adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 29, 2026
A STAT1/ETC/GBP1 axis represents a potential therapeutic target for noncommunicable granulomatous skin disease.

|Jan 10, 2024
Prostaglandin E2 controls the metabolic adaptation of T cells to the intestinal microenvironment.

Matteo Villa, David E Sanin, Petya Apostolova

|Nov 02, 2022
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade.

Michal A Stanczak, Natalia Rodrigues Mantuano, Nicole Kirchhammer

|Jul 20, 2022
NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity.

Nicole Kirchhammer, Marcel P Trefny, Marina Natoli

|Jun 23, 2021
Fever supports CD8+ effector T cell responses by promoting mitochondrial translation.

David O'Sullivan, Michal A Stanczak, Matteo Villa

|Apr 10, 2021
IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals.

Michal A Stanczak, David E Sanin, Petya Apostolova

Pageof 2

Frequent Collaborators

6 joint publications

David E Sanin

6 joint publications

Erika L Pearce

2 joint publications

Marcel P Trefny

2 joint publications

Nicole Kirchhammer